Search
Saul Ewing LLP will be a Bronze Sponsor at the 7th Annual LF Dealmakers Forum in NYC, September 17-19, 2024. Based on the success of IP Dealmakers – and our experience examining complex markets and bringing together influential groups in the converging fields of legal and finance – we launched the...
In a conversational 30-minute forum over Zoom, Saul Ewing attorneys hosted a monthly series discussing emerging industry developments and common issues that cannabis businesses face today. Interested in the full series? Learn more about additional dates and topics. For questions, please contact Mary...
Lawyers Only: Making Litigation Funding Better What are the best practices for firms to seek working capital? How do firms recommend funders for their clients? How are law firms contemplating using funding or investment for cases after filing? How does one navigating the ethical, privilege...
Litigation Risk Insurance; New Coverages; Risk Solutions; and Nuclear Claims? Litigation risk insurance, which for the most part, insures against adverse judgments or assists in preserving judgments, has become popular in the last few years. What is litigation risk insurance? How is it underwritten...
Breaking (free from) the Bank: Cannabis Litigation Finance This panel provides an overview of litigation finance, explores unique aspects of cannabis litigation that make cannabis litigation finance necessary, and provides resources for cannabis attorneys and their clients as they explore litigation...
Panel 4: The Connections Between Insurance and Litigation Funding Join Partner Brian Michalek and the University of Chicago Center on Law and Finance , in sponsorship with Burford Capital and Alliant, at the 2023 Chicago Conference on Litigation Finance. This conference will explore the policy...
Saul Ewing’s Casey Grabenstein and Andrew Schwerin write that courts are divided on whether plaintiff bias justifies discovery about litigation funding. They argue litigation funding wouldn’t often create a conflict of interest for a plaintiff.
Contingent Liability Insurance Demystified Partner Brian Michalek will speak on a panel during the 2023 Transaction Solutions Symposium. More information to come.
Join Saul Ewing as we participate in the largest annual gathering of in-house counsel in the world as a proud sponsor of the Association of Corporate Counsel Annual Meeting 2022. Visit us at Booth #318! Speaking Engagements: Monday, October 24, 2022 2:30 PM - 3:30 PM Length: 60 mins 409 - Pros and...
Steven Appelbaum is an experienced commercial litigator who represents individuals and companies involved in disputes related to real estate, creditor’s rights, corporate divorces, employment matters, and theft of trade secrets. Steven enjoys gaining a deep understanding of his clients’ business...
Luis Flores represents developers nationally in the acquisition, construction, development, leasing, refinancing and sale of vacant land, condominium projects, multifamily housing apartment complexes, hotels, commercial shopping centers, and commercial office buildings. Luis is also highly...
Jeff Shapiro handles sophisticated litigation nationwide for companies facing allegations of defective products and other crises that threaten their business, often in the context of multi-district litigation and class actions. During his 40 years as a trial lawyer, manufacturers of medical devices...
Martin Doyle concentrates his practice in commercial real estate transactions, with an emphasis on real estate acquisitions and dispositions, finance, and leasing. Martin has represented clients in transactions involving a wide array of property categories, including office, shopping center, retail...
Don Lussier represents clients in complex matters involving a wide range of commercial assets across the United States, including real estate, corporate and commercial lending transactions. Clients appreciate his ability to efficiently identify the issues that really matter, and to find creative and...
Industry-Specific, Business-Focused Legal Advice Increased pricing pressure combined with a rise in generic competition and continued regulatory uncertainty have squeezed the margins of life sciences companies. Helping navigate this ever-shifting terrain, Saul Ewing’s Life Sciences Practice consists...